Cargando…
Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through regulation of androgen receptor signaling in prostate cancer
Docetaxel is the standard chemotherapy for metastatic castration-resistant prostate cancer (CRPC). However, nearly all patients ultimately become refractory due to the development of docetaxel resistance. The transcribed ultraconserved regions (T-UCRs) are a novel class of non-coding RNAs that are a...
Autores principales: | Sekino, Yohei, Sakamoto, Naoya, Goto, Keisuke, Honma, Ririno, Shigematsu, Yoshinori, Sentani, Kazuhiro, Oue, Naohide, Teishima, Jun, Matsubara, Akio, Yasui, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706872/ https://www.ncbi.nlm.nih.gov/pubmed/29212226 http://dx.doi.org/10.18632/oncotarget.21688 |
Ejemplares similares
-
Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma
por: Sekino, Yohei, et al.
Publicado: (2018) -
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019) -
Non-coding RNAs are promising targets for stem cell-based cancer therapy
por: Sakamoto, Naoya, et al.
Publicado: (2017) -
Claspin overexpression is associated with high‐grade histology and poor prognosis in renal cell carcinoma
por: Kobayashi, Go, et al.
Publicado: (2020) -
Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)